Chimerix Total Assets 2011-2023 | CMRX
Chimerix total assets from 2011 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Chimerix Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $213 |
| 2022 | $279 |
| 2021 | $101 |
| 2020 | $85 |
| 2019 | $119 |
| 2018 | $191 |
| 2017 | $235 |
| 2016 | $287 |
| 2015 | $356 |
| 2014 | $292 |
| 2013 | $113 |
| 2012 | $32 |
| 2011 | $25 |
| 2010 | $0 |
| Chimerix Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $213 |
| 2023-09-30 | $225 |
| 2023-06-30 | $241 |
| 2023-03-31 | $259 |
| 2022-12-31 | $279 |
| 2022-09-30 | $294 |
| 2022-06-30 | $54 |
| 2022-03-31 | $66 |
| 2021-12-31 | $101 |
| 2021-09-30 | $133 |
| 2021-06-30 | $147 |
| 2021-03-31 | $159 |
| 2020-12-31 | $85 |
| 2020-09-30 | $94 |
| 2020-06-30 | $102 |
| 2020-03-31 | $108 |
| 2019-12-31 | $119 |
| 2019-09-30 | $128 |
| 2019-06-30 | $163 |
| 2019-03-31 | $178 |
| 2018-12-31 | $191 |
| 2018-09-30 | $199 |
| 2018-06-30 | $201 |
| 2018-03-31 | $215 |
| 2017-12-31 | $235 |
| 2017-09-30 | $246 |
| 2017-06-30 | $258 |
| 2017-03-31 | $272 |
| 2016-12-31 | $287 |
| 2016-09-30 | $297 |
| 2016-06-30 | $311 |
| 2016-03-31 | $324 |
| 2015-12-31 | $356 |
| 2015-09-30 | $392 |
| 2015-06-30 | $422 |
| 2015-03-31 | $274 |
| 2014-12-31 | $292 |
| 2014-09-30 | $194 |
| 2014-06-30 | $205 |
| 2014-03-31 | $102 |
| 2013-12-31 | $113 |
| 2013-09-30 | $120 |
| 2013-06-30 | $127 |
| 2013-03-31 | $26 |
| 2012-12-31 | $32 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $25 |
| 2010-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.082B | $0.000B |
| Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
| Stryker (SYK) | United States | $128.469B | 31.85 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| Boston Scientific (BSX) | United States | $99.939B | 33.23 |
| EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
| ResMed (RMD) | United States | $27.191B | 27.18 |
| Terumo (TRUMY) | Japan | $25.327B | 35.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
| Baxter (BAX) | United States | $20.095B | 14.66 |
| Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
| Insulet (PODD) | United States | $12.094B | 63.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.151B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
| BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
| Haemonetics (HAE) | United States | $4.275B | 21.86 |
| Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
| Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Envista Holdings (NVST) | United States | $3.399B | 12.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
| QuidelOrtho (QDEL) | United States | $2.695B | 9.78 |
| Neogen (NEOG) | United States | $2.634B | 25.33 |
| Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
| ICU Medical (ICUI) | United States | $2.347B | 17.51 |
| TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
| Owens & Minor (OMI) | United States | $1.903B | 18.27 |
| Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
| InMode (INMD) | Israel | $1.480B | 7.66 |
| National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
| LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
| AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
| Warby Parker (WRBY) | United States | $1.241B | 0.00 |
| AtriCure (ATRC) | United States | $1.117B | 0.00 |
| MacroGenics (MGNX) | United States | $1.044B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| Evolus (EOLS) | United States | $0.698B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
| Jin Medical (ZJYL) | China | $0.673B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
| Quanterix (QTRX) | United States | $0.610B | 0.00 |
| Valneva SE (VALN) | France | $0.556B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| PetIQ (PETQ) | United States | $0.477B | 17.80 |
| ZimVie (ZIMV) | United States | $0.427B | 26.15 |
| Biote (BTMD) | United States | $0.426B | 4.05 |
| OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
| Zynex (ZYXI) | United States | $0.391B | 45.00 |
| Surmodics (SRDX) | United States | $0.379B | 40.92 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
| Veru (VERU) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
| Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
| InterCure (INCR) | Israel | $0.108B | 18.23 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.12 |
| Safety Shot (SHOT) | United States | $0.102B | 0.00 |
| MariMed (MRMD) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Brainsway (BWAY) | Israel | $0.085B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.91 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |